Introduction
Human genomic variation in the form of single nucleotide substitutions has been catalogued in incredible detail since the completion of the draft human genome sequence in 2000. The HapMap project, which by 2007 had documented more than 3·1 million single nucleotide polymorphisms (SNPs) and their inter-relation, has underpinned subsequent successful genome-wide association studies. 1 While findings from these studies were showing novel SNP associations for a range of common diseases, 2 and 3 detailed efforts were underway to comprehensively map submicroscopic structural variants across the human genome. 4, 5, 6, 7, 8, 9 , 10, 11 and 12 Use of emerging molecular biology technologies has shown that the extent of structural genomic variation is much greater than was previously suspected. 12, 13 and 14 In view of the established role of large deletions, duplications, and other structural rearrangements in specific diseases termed genomic disorders, 15 and 16 these discoveries have excited interest about the contribution of intermediate-scale structural genomic variation to disease risk. Structural variation caused by a variable number of copies of a particular DNA segment are referred to as copy number variants. 17 Much of the scientific infrastructure to support genome-wide association studies of copy number variation has already been established to undertake genome-wide SNP-based association studies including consortia of studies to achieve large total sample sizes. 2 Genome-wide SNP association studies could be supplemented with association studies of copy number variation by use of existing SNP data or by the undertaking of appropriate further assays. 2 The potential role of copy number variation in complex diseases, 18 36 Although some of these associations could be false positives, others have had either technical validation or replication of findings in different study populations, or both.
These validated associations are probably a direct or an indirect result of changes to the copy number of the relevant genomic sequence.
Understanding of the disease mechanisms of a range of common diseases could soon be informed by the discovery of copy number variants associated with predisposition to disease. However, many challenges lie ahead for the reliable detection of such associations.
The location, size, and boundaries (breakpoints) of these variants documented in public databases have been very imprecise, although the new generation of maps of copy number variants are providing much improvement. 14 and 37 Scalable methods to characterise copy number variation in association studies have been inexact. New genome-wide SNP arrays have advanced coverage and resolution, but the potential for misclassification remains much higher for variations in copy number than for SNPs. 14, 38 and 39 Furthermore, studies of this variation are constrained by the same issues of power, differential bias, and extreme multiple-testing that are encountered by SNP-based association studies. In this Review, we introduce copy number variation, examine advances in our understanding, and discuss the inferences that can be reasonably drawn from association studies of copy number variation.
Definition
For nearly all genes in the human genome, we inherit one copy from each parent, so that we have two copies in the nucleus of every diploid cell. However, the copy number per genome varies for some genes. For example, a cluster of several β-defensin genes shows common copy number variation of between two and seven copies per diploid cell, and occasionally copy numbers are as high as ten or 11. 40 Similarly, the salivary amylase gene, AMY1, varies in copy number from two to 15 with a mean of seven in the EuropeanAmerican population. 41 The simplest type of copy number variation is the presence or absence of a gene ( figure   1A )-eg, in Europe, the rhesus-negative allele at the main antigen locus for the rhesus blood group is commonly caused by complete deletion of the RHD gene. 42 Copy number variation is a subset of the broad occurrence of genomic structural variation, which is any variation exceeding that detected for SNPs or microsatellite variation (blocks of two-six bp repeated ten-100 times). The range of structural genomic variation includes rearrangements such as inversions, which change the orientation of a DNA segment, and balanced translocations, in which a DNA segment is reciprocally exchanged between two chromosomes. These rearrangements change the spatial organisation of DNA but do not result in any net gain or loss of sequence. Copy number variation is not simple to define either rigidly or rationally. For example, tandemly repeated minisatellites, insertions of mobile genetic elements, and highly repeated tandem arrays of genes (eg, ribosomal RNA genes) share common features with copy number variants, but are generally considered separately.
Somewhat arbitrarily, copy number variation usually refers to DNA sequences of about 1000 bp (1 kb) or more. The Database of Genomic Variants 4 (panel 1) records structural variants of 1 kb or more of DNA, but regards those in the 100-1000 bp range to be in a separate category of indel. This artificial division within a continuous range has been historically defined by the size limits of the methods used to detect copy number variation, including sequencing. Although extreme differences are often clear, no hard and fast criterion can distinguish copy number variants from large-scale structural genomic variation that has been implicated in syndromic anomalies and diseases, which are referred to as genomic disorders (figure 2).
Researchers investigating the potential effect of copy number variation on human health and disease can probably learn from the study of genomic disorders (panel 2 
Functional consequences
If copy number variation affects entire genes, especially those with important effects on biological function, it would naturally be expected to affect susceptibility to disease. The number of copies of the chemokine gene CCL3L1 varies within and between populations; in Europe, common variation is from zero to four copies, whereas in Africa, copy numbers as high as ten have been recorded. In fact, the copy number of CCL3L1 is associated with chemokine concentrations, the proportion of CD4+ cells expressing the chemokine receptor CCR5, viral loads, and the rate of AIDS progression (low copy number is associated with susceptibility to HIV-1 infection). 34 and 36 So far, evidence is consistent with a gradation of risk corresponding to CCL3L1 copy number. Similarly the copy number of AMY1 is correlated with salivary amylase protein concentration and dietary starch consumption across populations sampled from Africa, Asia, and Europe. 41 Of particular clinical interest is CYP2D6, which affects the metabolism of about 50% of drugs including tricyclic antidepressants, selective serotonin reuptake inhibitors, antipsychotics, antiarrhythmics, β blockers, opioid analgesics, antiemetics, and antihistamines. The highly polymorphic copy number of CYP2D6 affects expression of the cytochrome P450 enzyme CYP2D6, and contributes substantially to the variation in drug metabolism between individuals. 59 By contrast, the number of copies of the X chromosome green photopigment gene, OPN1MW, is highly variable but only the first gene copy seems to be expressed. Second and subsequent copies of OPN1MW on the X chromosome are postulated to be located too far from the regulatory region (termed the locus control region) to be activated, so that OPN1MW duplications do not affect colour vision. Rather, defects in colour vision could be caused by hybrid red-green (OPN1LW-OPN1MW) genes, gene deletions, or sequence variation. 60 The clinical consequences of copy number variation might not always be in direct proportion to gene dosage. 61 The functional effect could crucially depend on whether the copy number variant changes the sequence or relative location of specific segments of genomic DNA that act as enhancers or suppressors of gene expression. 62 Redon and colleagues 12 showed that genes within regions of copy number variation were over-represented by Gene Ontology categories related to several environmental sensor functions, such as cell adhesion, sensory perception, chemical stimuli, and neurophysiological processes. This bias could be caused by positive or balancing selection for different copy numbers at these environmental sensor genes, indicating variable selection pressure. Alternatively, copy number variation in these gene categories might be better tolerated than in other gene categories for which variation might cause harm and therefore would be quickly removed by selection.
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Mapping of copy number variation
Discovery of copy number variation has been accelerated by systematic genome-wide application of array comparative genomic hybridisation, next generation sequencing, and SNP genotyping arrays. Nevertheless, several copy number variants were identified between 10 and 20 years ago by standard methods of molecular genetic analysis at individual genetic loci, including Southern blotting, cytogenetic methods, and PCR-based approaches.
Cytogenetic studies have used techniques such as fluorescent in-situ hybridisation to define two major structural variants on chromosome 8 (p23.1): the so-called euchromatic variant caused by high copy number of a repeat containing β-defensin genes, 40 and common inversion of nearly the whole chromosome band that is carried in a heterozygous state by about a quarter of European people and about a third of Japanese people. 
Developed maps of copy number variation
An assay of 270 HapMap individuals on an Affymetrix 6.0 array has been used to produce a map of copy number variation of much higher resolution (about 2 kb) than have maps derived from BAC arrays. This map cast doubt about previous assumptions of the frequency, size, and origin of copy number variants. 14 For example, copy number variant sizes were between five and 15 times smaller than were shown by BAC arrays 12 and almost half were reported in multiple unrelated individuals. 14 Most copy number variants were inherited, and although some were less easily tagged than SNPs of an equivalent frequency, common copy number variants tended to show strong linkage disequilibrium with a HapMap SNP. Several such variants that had been previously judged as complex, were explained by two separate simple copy number variants co-occurring on homologous chromosomes (copy number measurements are for the diploid genome).
14 The knowledge gained from this map 14 has several important implications. First, if most copy number variants are stably inherited at an appreciable frequency in the population, most common copy number variants might be expected to have an individually modest effect on disease risk. Second, most small copy number variants with frequency greater than 1% are also diallelic and in Hardy-Weinberg equilibrium, and thus are analogous to SNPs.
Third, some such copy number variants associated with disease might also show association with a nearby SNP. The corollary is that some findings from genome-wide association studies could be explained by copy number variation, as can the signal of association with
Crohn's disease from SNPs in the region of IRGM.
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Association studies
Many years before the surge of interest in the association between copy number variation and disease, some associations were identified by candidate gene studies with lowthroughput molecular methods to measure copy number. Examples include association of the α-globin copy number variant with α-thalassaemia and malaria resistance, 79 and 80 and the association between RHD gene deletion and haemolytic disease of newborn children.
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and 81 The link between deficiencies in the complement factor 4 gene (C4A/C4B) and systemic lupus erythematosus is also well established; 82 Yang and co-workers 32 confirmed that low copy number of these genes is a risk factor. Regions containing genes of the immune system, especially the innate immune and complement systems, tend to be copy number variable and have been the subject of many candidate gene association studies.
FCGR3B encodes a variant of the type III IgG receptor. The gene has variable copy number, and low copy number is associated with glomerulonephritis in systemic lupus erythematosus. 30 Further studies have shown that low FCGR3B copy number is associated with a range of systemic autoimmune diseases, including systemic lupus erythematosus, polyangiitis, and Wegener's granulomatosis. 31 Sequence variation in the complement factor H and related genes can increase the risk of age-related macular degeneration, whereas deletion of the related genes CFHR1 and CFHR3 protects against the disorder 83 and predisposes individuals to atypical haemolytic-uraemic syndrome. 84 However, the effect of the deletion is modified by other risk factors, including risk alleles present on non-deletion chromosomes. Once these other factors are accounted for, the protective effect of the deletion on age-related macular degeneration might only be modest. 85 A unit of seven β-defensin genes has variable copy number on chromosome 8. 40 These genes, including DEFB4, encode antimicrobial peptides, but findings from additional studies have suggested that the genes have diverse functions such as chemokine activity. 86 Low copy number has been associated with Crohn's colitis, 87 and high copy number with predisposition to psoriasis.
29
As mentioned above, the chemokine genes CCL3L1 and CCL4L1 are both present on a unit of variable copy number, 88 which shows interesting differences in variation between European (generally zero-four copies) and African populations (four-ten copies Many candidate gene associations relate to multiallelic copy number variants, which could indicate either an increased biological propensity for multiallelic variants to affect function, or a tendency for multiallelic variants to be selected as candidates for association studies.
Artifactual associations might be more probable with multiallelic than with diallelic copy number variants because of the technical difficulties with accurate genotyping.
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Design of association studies 13 The examples of genome-wide association studies mentioned previously reported large rare copy number variants, which might identify important subgroups of some common diseases. 12 , 21 and 27 Crucially, such studies have often used genome-wide arrays with inadequate resolution to study small common copy number variants and filtering strategies that tend to exclude such variants.
Consequently, different strategies are needed to study common copy number variants.
Almost all the factors that are relevant to SNP-based association studies are also important for the design of association studies of copy number variation. Therefore, we consider some aspects of the design, analysis, and reporting of association studies of copy number variation from an epidemiological perspective. SNP association studies 2, 93, 94, 95 and 96 and copy number variation association studies 39 and 95 have been reviewed in detail previously.
Adequate statistical power to detect the generally modest effects expected for common copy number variants is only likely to be achieved through large sample sizes. If common copy number variants exert effects on disease risk that are as modest as those often recorded for common SNPs, then at least several thousand cases and controls will be needed, and study size will need to increase if typing of copy number variation has an appreciable measurement error. 97 Do copy number variants need to be measured directly (panel 3) or can they be measured adequately through linkage disequilibrium (tagging) from nearby SNPs? Estimation of the proportion of copy number variants across the genome that can be effectively tagged by neighbouring SNPs has varied substantially, which is unsurprising in view of differences in the accuracy of genotyping of copy number variation and the density of SNP genotyping. Most common copy number variants (allele frequency >5%) detected by McCarroll and colleagues 14 from an Affymetrix 6.0 array were in perfect linkage disequilibrium with a
HapMap SNP. Although copy number variants were less well captured than were SNPs of an equivalent allele frequency, the mean pairwise r 2 as a function of distance was similar for both, suggesting that this reduced tagging was caused by a paucity of SNPs in the relevant regions, rather than recurrent mutations. Even on first-generation SNP arrays, 40-50% of common copy number variants (allele frequency >5%) were tagged (r 2 >0·8) and this proportion was increased with the newest arrays (about 65% for the Illumina 1M array).
14 Of the common copy number variants detected with the Illumina Human 1M array by
Cooper and colleagues, 38 about 50% were tagged by the newest arrays (54% for the Illumina 1M array). These estimates need to be refined, ideally with copy number variants ascertained from independent approaches, but evidence suggests that SNP arrays can capture a substantial proportion of simple deletions through linkage disequilibrium with neighbouring SNPs. However, the remainder of simple and almost all complex multiallelic copy number variants will not be adequately captured by tag SNPs. Comprehensive association studies will therefore need such variants to be measured directly (panel 3).
Statistical models to test association are usually straightforward compared with the complex statistical approaches used by calling algorithms for copy number variants. An additive genetic model is usually assumed in SNP association tests, 2 and this model would be an appropriate starting point for association studies of copy number variation to test dose dependency. Such a model assumes that the diploid copy number has an additive relation to the log odds ratio of disease, which is equivalent to a multiplicative effect on the odds ratio.
Primary association tests do not need to be adjusted for a wide range of covariates in association studies of copy number variants or SNPs, since associations can be masked if the relevant covariate is an intermediate on the causal pathway. Furthermore, phenotypic and lifestyle characteristics do not confound associations between a disease and a genotype because the genotype is randomly assigned at meiosis (mendelian randomisation).
Presentation of findings adjusted in this way leaves scope for data-derived selection of the most noteworthy model and can be misleading. 98 Many issues that seem unique to studies of copy number variation are, in fact, special cases of problems encountered generally in epidemiological studies, such as misclassification. 93 For example, overlapping but non-identical copy number variants might be collectively assigned into one exposure category, on which tests of association between variation and disease would be based. This classification is correct when the variant breakpoints differ only because of measurement error; however, if the differences in breakpoints represent separate biological events with differing phenotypic consequences, the resulting misclassification will bias the findings of any association test.
In SNP-based association studies, over-stringent quality thresholds for SNP genotype calling can cause differential misclassification of genotypes between cases and controls (differential bias). 99 Similarly, in the context of an association study of copy number variation, calling as missing data copy number variant calls that are less than certain could cause or exacerbate differential bias. Incorporation of this uncertainty into the association testing would be preferable, for example by weighting the call according to the posterior probability of the call. The importance of differential bias might decrease as the accuracy of assays for copy number variation improves, but until then, methods that take appropriate account of the uncertainty in calling will be advantageous. One approach to keep differential bias to a minimum is to combine calling and association testing into one statistical procedure. 100 The choice of statistical threshold for declaring associations to be significant demands careful examination for copy number variation. In genome-wide association studies based on SNP genotypes, artifactual associations tend to be over-represented among the smallest p values. 3 Even when the distribution of p values does not indicate obvious sources of bias, the use of a very low p value threshold does not, on its own, provide any guarantee of causal association. 2 Presently, the number of copy number variants across the human genome is not known, and therefore a correction for multiple testing based on this number is not possible to define. A cautious approach would be to use a threshold for genome-wide association tests of copy number variation similar to those used for SNPs (eg, p<5×10 −7 ). 3 By comparison, a less-stringent threshold would be appropriate for candidate gene studies, provided that the selective reporting of only significant associations can be kept to a minimum.
In either case, results should be interpreted in view of the power of the study and existing evidence. The false-positive report probability can also be a helpful adjunct for reporting of study findings since this value explicitly acknowledges existing evidence and the power of the study. 101 Replication is central to assessment of the robustness of results from genomewide SNP association studies, and therefore association studies of copy number variation are likely to be similar in this respect. If replication is not feasible, investigators should be encouraged to report findings fully to allow broad replication efforts. Furthermore, replication studies should ideally be powered to detect a smaller effect size than that reported in the original study.
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Future prospects
Rapid advances in our understanding of the nature of copy number variation in the human genome have been made in the past 5 years. The resolution of emerging maps of copy number variation seems to be improving to one probe per 50 bp. 37 Genome-wide and candidate region approaches to detect copy number variation are also improving, together with statistical calling algorithms that can take account of the information provided by maps of copy number variation. We seem to be on the threshold of new discoveries in association studies of copy number variation and of developing our understanding of the contributions of sequence and structural variations to predisposition to common diseases.
Search strategy and selection criteria
We searched PubMed with the terms "copy number variation" and "structural variation" for The most satisfactory records of copy number variants will be those for which the structural basis has been defined, ideally based on the DNA sequence, and for which frequencies have been established by population surveys.
Panel 2. Genomic disorders
Genomic disorders are diseases attributable to genomic rearrangements that occur as a result of specific genome architecture. 15 Lupski 16 described four examples that take place on the proximal short arm of chromosome 17. This region is rich in segmental duplications, which are thought to predispose to genomic rearrangements.
Charcot-Marie-Tooth neuropathy 1A (CMT1A) is a well characterised genomic disorder, and most cases result from tandem duplication (17)(p12) of a 1·4 million bp (1·4 Mb) region. Generally, association studies based on either genome-wide or candidate region data cannot produce accurate copy number estimates for the large number of samples needed for case-control association studies. 78 Both new genotyping arrays and use of a-priori data from updated maps of copy number variation (about variant locations and breakpoints) have improved accuracy. 14 and 75 However, typing in most published association studies of copy number variation is subject to substantial measurement error; validation and replication of findings is crucial. Array comparative genomic hybridisationTest and reference DNA samples are differentially labelled, mixed, and passed over a target array of probes (eg, BAC clones or oligonucleotides) containing DNA fragments from across the whole human genome. The experiment is often repeated with reversal of the test and reference dyes to detect dye effects or identify spurious signals. DNA samples hybridise with their corresponding probe, and the ratio of fluorescence from each probe (test:reference) is used to detect regions that vary in copy number between the test and the reference sample (red line: original hybridisation; blue line: dye-swapped hybridisation). Equal copy number for both the test and reference DNA is identified by equal binding, resulting in a ratio of one. Duplication in a genomic region of the test sample is identified by an increased ratio, and a deletion by a decreased ratio, but a deletion in the test sample is indistinguishable from a duplication in the reference sample. These ratios are usually converted to log 2 scale for further analysis. Adapted from Feuk and colleagues 17 with permission from Nature Reviews Genetics. 
